Arvin AM - Search Results

1

Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.

Arvin AM, Moffat JF, Sommer M, Oliver S, Che X, Vleck S, Zerboni L, Ku CC. Arvin AM, et al. Curr Top Microbiol Immunol. 2010;342:189-209. doi: 10.1007/82_2010_29. Curr Top Microbiol Immunol. 2010. PMID: 20397071 Free PMC article. Review.

2

Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.

Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Wilson A, et al. Among authors: arvin am. J Infect Dis. 1992 Jan;165(1):119-26. doi: 10.1093/infdis/165.1.119. J Infect Dis. 1992. PMID: 1309369

3

Cell-mediated immunity to varicella-zoster virus.

Arvin AM. Arvin AM. J Infect Dis. 1992 Aug;166 Suppl 1:S35-41. doi: 10.1093/infdis/166.supplement_1.s35. J Infect Dis. 1992. PMID: 1320649 Review.

4

Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.

Lowry PW, Solem S, Watson BN, Koropchak CM, Thackray HM, Kinchington PR, Ruyechan WT, Ling P, Hay J, Arvin AM. Lowry PW, et al. Among authors: arvin am. J Gen Virol. 1992 Apr;73 ( Pt 4):811-9. doi: 10.1099/0022-1317-73-4-811. J Gen Virol. 1992. PMID: 1321876

5

Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.

Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J. Arvin AM, et al. J Immunol. 1991 Jan 1;146(1):257-64. J Immunol. 1991. PMID: 1670603

6

Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.

Bergen RE, Sharp M, Sanchez A, Judd AK, Arvin AM. Bergen RE, et al. Among authors: arvin am. Viral Immunol. 1991 Fall;4(3):151-66. doi: 10.1089/vim.1991.4.151. Viral Immunol. 1991. PMID: 1725699

7

Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.

Diaz PS, Au D, Smith S, Amylon M, Link M, Smith S, Arvin AM. Diaz PS, et al. Among authors: arvin am. Pediatrics. 1991 Feb;87(2):166-70. Pediatrics. 1991. PMID: 1846236

8

Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.

Koropchak CM, Graham G, Palmer J, Winsberg M, Ting SF, Wallace M, Prober CG, Arvin AM. Koropchak CM, et al. Among authors: arvin am. J Infect Dis. 1991 May;163(5):1016-22. doi: 10.1093/infdis/163.5.1016. J Infect Dis. 1991. PMID: 1850441

9

The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content.

Bergen RE, Diaz PS, Arvin AM. Bergen RE, et al. Among authors: arvin am. J Infect Dis. 1990 Nov;162(5):1049-54. doi: 10.1093/infdis/162.5.1049. J Infect Dis. 1990. PMID: 2172393 Clinical Trial.

10

T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.

Diaz PS, Smith S, Hunter E, Arvin AM. Diaz PS, et al. Among authors: arvin am. J Immunol. 1989 Jan 15;142(2):636-41. J Immunol. 1989. PMID: 2536059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

404 results

Search Page

Filters